Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapy

European Journal of Cancer

Volumn 34, Issue 1, 1998, Pages 81-86

  Nooter, K ^a   Kok, T ^a   Bosnian, F T ^b,c   Van Wingerden, K E ^a   Stoter, G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Clinical response; Immunohistochemistry; MRP; Pre operative chemotherapy; Squamous cell carcinoma of the oesophagus

Indexed keywords

CISPLATIN; ETOPOSIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; ETOPOSIDE; FEMALE; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RNA, MESSENGER;

EID: 0031915537     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00356-0     Document Type: Article

References (36)

1. Kok TC. Chemotherapy in esophageal cancer. Cancer Treat Rev 1997, 23, 65-85.
2. Kok TC, van Lanschot J, Siersema PD, van Overhagen H, Tilanus HW. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer; final report of a phase III multicenter randomized controlled trial. Proc Am As.ioc Clin Oncol 1997, 16, 277.
3. Nooter K, Westerman AM, Flens MJ, et al. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1995, 1, 1301-1 310.
4. Cole SPC, Bhardwaj G, Gerlach JH, et al., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258, 1650-1654.
5. Hipmer DR, Gauldie SD, Deeley RG, Cole SPC. Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 1994, 54, 5788-5792.
6. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994, 54, 5902-5910.
7. Grant CE, Valdimarsson G, Hipmer DR, Almquist KG, Cole SPC, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994, 54, 357-361.
8. Kruh GD, Chan A, Myers K, Gaughan K, Miki T, Aaronson SA. Expression complementary DNA library transfer establishes MRP as a multidrug resistance gene. Cancer Res 1994, 54, 16491652.
9. Zaman GJR, Flens MJ, van Leusden MR, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Nat! Acad Sei USA 1994, 91, 8822-8826.
10. Breuninger LM, Paul S, Gaughan K, e:- al. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 1995, 55, 5342-5347.
11. Paul S, Breuninger LM, Tew KD, Shen H, Kruh GD. ATPdependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. Proc NatlAcad Sei USA 1996, 93, 692C-6934.
12. Ota E, Abe Y, Oshika Y, et al. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 1995, 72, 550-554
13. Nooter K, Bosman FT, Burger H, et a', Expression of the multidrug resistance-associated protein (MRP) gene in primary nonsmall-cell lung cancer. Ann Oncol 1996, 7, 75-81.
14. Endo K, Maehara Y, Ichiyoshi Y, et al. Multidrug resistanceassociated protein expression in clinical gastric carcinoma. Cancer, 1996,77 1681-1687.
15. Kavallaris M, Leary JA, Barren JA, Frkdlander ML. MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors. Cancer Lett 1996, 102, 7-16.
16. Filipits M, Suchomel RW, Dekan G, et al. MRP and MDR1 gène expression in primary breast carcinomas. Clin Cancer Res 1996,2, 1231-1237.
17. Clifford SC, Neal DE, Lunée J. Altérations in expression of the multidrug resistance-associated protein (MRP) gene in highgrade transitional cell carcinoma of the bladder. Br J Cancer 1996, 73, 659-666.
18. Morris MD, Bordow SB, Marshall GM, Haber PS, Conn SL, Haber M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N EnglJ Med 1996, 334, 231-238.
19. Nooter K, Brutel de la Riviere G, Look MP, et al. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. BrJ Cancer 1997, 76, 486-493.
20. Nooter, K, Brutel de la Riviere G, Klijn JGM, Stoter G, Foekens JA. Multidrug resistance protein (MRP) in recurrent breast cancer. The Lancet, 1997,349, 1885-1886.
21. Burger H, Nooter K, Zaman GJR, et al. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia 1994, 8, 990-997.
22. Burger H, Nooter K, Sonneveld P, van Wingerden KE, Zaman GJR, Stoter G. High expression of the multidrug resistanceassociated protein (MRP) in chronic and prolymphocytic leukemia. BrJHaematol 1994, 88, 348-356.
23. Schneider E, Cowan KH, Bader H, et al. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 1995, 85, 186-193.
24. Hermanek P, Sobin LH. TNM classification of Malignant Tumours. Berlin, Springer, 1992.
25. Fellous M, Nir U, Wallach D, Merlin G, Rubinstein M, Revel M. Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Nat! Acad Sei USA 1982, 79, 3082-3086.
26. Zaman GJR, Versantvoort CHM, Smit JJM, et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res, 1993, S3, 1747-1750.
27. Flens MJ, Izquierdo MA, Scheffer GL, et al. Immunochemical detection of multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994, 54, 4557-4563.
28. Flens MJ, Zaman GJR, van der Valk P, et cd. Tissue distribution of the multidrug resistance protein. Am J Paihol 1996, 148, 1237-1247.
29. Clynes M. Multiple Drug Resistance in Cancer. Cellular, Molecular and Clinical Approaches. Dordrecht, Kluwer, 1993.
30. Hofmann GA, Mattern MR. Topoisomerase II in multiple drug resistance. Cytotechnology 1993, 12, 137-154.
31. Moscow JA, Dixon KH. Glutathione-related enzymes, glutathione and multidrug resistance. Cytotechnology 1993, 12, 155170.
32. Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 1993, 85, 632-639.
33. Müller M, Meijer C, Zaman GJR, et al.Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sei USA 1994, 91, 13033-13037.
34. Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D. ATPdependent transport of glutathione-S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994, 54, 4833-4836.
35. I-eier I, Jedlitschky G, Buchholz U, Cole SPC, Deeley RG, Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J BiolChem 1994, 26, 27807-27810.
36. Ishikawa T, Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells: molecular characterization of glutathioneplatinum complex and its biological significance. J Biol Chem 1993, 268, 20116-20125.